The Q-REDUCE Study
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-99
SponsorUniversity of Southern Denmark
About this trial
The purpose of this study is to design a fast-track pathway for patients referred to the University Hospital of Southern Denmark, Esbjerg, with high probability of having a dislocated hip prosthesis with the primary aim to reduce the time from arrival to reduction and the total hospitalization time. Secondary aims are to
* investigate whether quicker prosthesis reduction influences on hip function and quality of life afterwards * reduce the pain experience immediately and in the long term * increase patient satisfaction
without changing the overall complication rate and readmission/mortality
Eligibility criteria
Qualifiers
a history of either a THA or a HA in combination with at least one of the following terms
having sustained a sudden, incorrect movement or twist in the hip joint in either a bending, sitting or supine position leading to inability to stand or walk
misalignment of the concerned lower extremity (typically shortened, with inward/outward rotation)
Disqualifiers
recurrent dislocations during the same hospital admission (already "in the house")
anticipated difficult airway by the attending anesthesiologist
anticipated need for extended respiratory or hemodynamic monitoring by the attending anesthesiologist
American Society of Anesthesiologists (ASA) score > 3
Trial design
Treatments tested in this trial
- Fasttrack pathway for THA/HE prosthesis reduction
- Standard pathway for THA/HE prosthesis reduction
Treatment groups
120 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
University of Southern Denmark
Lead sponsor
Esbjerg Hospital - University Hospital of Southern Denmark
Collaborator
Source ClinicalTrials.gov